BofA lowered the firm’s price target on Carter’s (CRI) to $25 from $30 and keeps an Underperform rating on the shares following the Q2 earnings miss. The firm remains cautious on the shares citing Carter’s challenging margin outlook from tariffs and the investments needed to improve its trends.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRI:
